Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1998 2
2000 1
2004 3
2005 3
2006 1
2007 1
2008 3
2009 1
2010 1
2011 2
2013 1
2014 1
2015 2
2016 1
2017 2
2018 3
2019 2
2020 1
2021 3
2022 2
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Osteogenesis imperfecta type 16"
Page 1
Primary osteoporosis.
Bishop N. Bishop N. Endocr Dev. 2009;16:157-69. doi: 10.1159/000223694. Epub 2009 Jun 3. Endocr Dev. 2009. PMID: 19494666 Review.
Primary osteoporosis, as defined by bone loss associated with significant fracture, is most commonly caused in children by one or other of the forms of osteogenesis imperfecta (OI). These are a group of disorders that are characterised by abnormalities in type …
Primary osteoporosis, as defined by bone loss associated with significant fracture, is most commonly caused in children by one or other of t …
What type of valve is most appropriate for osteogenesis imperfecta patients?
Dimitrakakis G, Challoumas D, von Oppell UO. Dimitrakakis G, et al. Interact Cardiovasc Thorac Surg. 2014 Sep;19(3):499-504. doi: 10.1093/icvts/ivu152. Epub 2014 May 29. Interact Cardiovasc Thorac Surg. 2014. PMID: 24876219 Review.
A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was in osteogenesis imperfecta (OI) patients with valve disease undergoing valve replacement which type of valve (bioprosthetic or mechanical) is m …
A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was in osteogenesis …
Clinical, genetic characteristics and treatment outcomes of children and adolescents with osteogenesis imperfecta: a two-center experience.
Erbaş İM, İlgün Gürel D, Manav Kabayeğit Z, Koç A, Ünüvar T, Abacı A, Böber E, Anık A. Erbaş İM, et al. Connect Tissue Res. 2022 Jul;63(4):349-358. doi: 10.1080/03008207.2021.1932853. Epub 2021 Jun 9. Connect Tissue Res. 2022. PMID: 34107839
BACKGROUND: Osteogenesis imperfecta (OI), is a heritable, heterogeneous connective tissue disorder, characterized by fragile bones. ...MATERIALS AND METHODS: A two-center retrospective study was conducted using demographic, clinical, and genetic data obtained …
BACKGROUND: Osteogenesis imperfecta (OI), is a heritable, heterogeneous connective tissue disorder, characterized by fragile b …
An exploratory open-label multicentre phase I/II trial evaluating the safety and efficacy of postnatal or prenatal and postnatal administration of allogeneic expanded fetal mesenchymal stem cells for the treatment of severe osteogenesis imperfecta in infants and fetuses: the BOOSTB4 trial protocol.
Sagar RL, Åström E, Chitty LS, Crowe B, David AL, DeVile C, Forsmark A, Franzen V, Hermeren G, Hill M, Johansson M, Lindemans C, Lindgren P, Nijhuis W, Oepkes D, Rehberg M, Sahlin NE, Sakkers R, Semler O, Sundin M, Walther-Jallow L, Verweij EJTJ, Westgren M, Götherström C. Sagar RL, et al. BMJ Open. 2024 Jun 4;14(6):e079767. doi: 10.1136/bmjopen-2023-079767. BMJ Open. 2024. PMID: 38834319 Free PMC article. Clinical Trial.
INTRODUCTION: Severe osteogenesis imperfecta (OI) is a debilitating disease with no cure or sufficiently effective treatment. Mesenchymal stem cells (MSCs) have good safety profile, show promising effects and can form bone. The Boost Brittle Bones Before Birth (BOOS …
INTRODUCTION: Severe osteogenesis imperfecta (OI) is a debilitating disease with no cure or sufficiently effective treatment. …
Bone allografting: an original method for biological osteosynthesis and bone reinforcement in children with osteogenesis imperfecta.
Gaume M, El Yahiaouni S, De Tienda M, Baujat G, Cormier-Daire V, Dumaine V, Pannier S, Finidori G, Pejin Z. Gaume M, et al. Int Orthop. 2023 Jul;47(7):1863-1869. doi: 10.1007/s00264-023-05818-6. Epub 2023 May 12. Int Orthop. 2023. PMID: 37171515
PURPOSE: Osteogenesis imperfecta (OI) is a genetic disorder responsible for various symptoms including deformities and frequent fractures. ...METHODS: Thirty-nine lower limb allograft procedures (28 femurs, 11 tibias) were performed in 26OI patients (mean age, 12.9 …
PURPOSE: Osteogenesis imperfecta (OI) is a genetic disorder responsible for various symptoms including deformities and frequen …
Cyclic intravenous pamidronate for an infant with osteogenesis imperfecta type II.
Fukahori K, Nirei J, Yamawaki K, Nagasaki K. Fukahori K, et al. BMJ Case Rep. 2023 May 15;16(5):e252593. doi: 10.1136/bcr-2022-252593. BMJ Case Rep. 2023. PMID: 37188488
Fetal CT at 28 weeks' gestation showed decreased ossification of the skull, a small bell-shaped thorax, hypoplastic vertebrae, and shortening and bowing of the long bones, leading to the diagnosis of osteogenesis imperfecta (OI) type II. The newborn was deliv …
Fetal CT at 28 weeks' gestation showed decreased ossification of the skull, a small bell-shaped thorax, hypoplastic vertebrae, and shortenin …
Bisphosphonate Treatment and the Characteristics of Femoral Fractures in Children With Osteogenesis Imperfecta.
Vuorimies I, Mäyränpää MK, Valta H, Kröger H, Toiviainen-Salo S, Mäkitie O. Vuorimies I, et al. J Clin Endocrinol Metab. 2017 Apr 1;102(4):1333-1339. doi: 10.1210/jc.2016-3745. J Clin Endocrinol Metab. 2017. PMID: 28323993
CONTEXT: The short-term benefits of bisphosphonates (BPs) are evident in the treatment of children with osteogenesis imperfecta (OI), but some concerns related to long-term effects remain. ...The pattern of femoral fractures was similar in all three BP treatment gro …
CONTEXT: The short-term benefits of bisphosphonates (BPs) are evident in the treatment of children with osteogenesis imperfecta …
Tibial Sliding Elastic Nailing Technique in Moderate-to-Severe Osteogenesis Imperfecta: Long-term Outcomes.
Gaume M, Duprot E, De Tienda M, Pannier S, Baujat G, Finidori G, Pejin Z. Gaume M, et al. J Pediatr Orthop. 2022 Jan 1;42(1):47-52. doi: 10.1097/BPO.0000000000001996. J Pediatr Orthop. 2022. PMID: 34723894
BACKGROUND: Osteosynthesis of leg fractures and deformities in children with osteogenesis imperfecta should align the skeleton and overcome its fragility during growth with a telescopic effect. ...METHODS: A total of 22 children with an average age of 4.7 years were …
BACKGROUND: Osteosynthesis of leg fractures and deformities in children with osteogenesis imperfecta should align the skeleton …
Surgical Outcome of Spinal Fusion for Osteogenesis Imperfecta With Scoliosis: Is the Hybrid System With Pedicle Screws Applicable to Weak, Tiny, and Fragile Vertebrae?
Ito M, Kakutani K, Miyamoto H, Suzuki T, Yurube T, Uno K. Ito M, et al. J Pediatr Orthop. 2021 Jul 1;41(6):368-373. doi: 10.1097/BPO.0000000000001829. J Pediatr Orthop. 2021. PMID: 34096550
INTRODUCTION: Corrective surgery for spinal deformity associated with osteogenesis imperfecta (OI) is challenging due to the severe and rigid deformity combined with extreme bone fragility. ...Mean follow-up was 5.82.0 years. The Sillence classification showed 16 …
INTRODUCTION: Corrective surgery for spinal deformity associated with osteogenesis imperfecta (OI) is challenging due to the s …
Pain and quality of life of children and adolescents with osteogenesis imperfecta over a bisphosphonate treatment cycle.
Tsimicalis A, Boitor M, Ferland CE, Rauch F, Le May S, Carrier JI, Ngheim T, Bilodeau C. Tsimicalis A, et al. Eur J Pediatr. 2018 Jun;177(6):891-902. doi: 10.1007/s00431-018-3127-9. Epub 2018 Apr 11. Eur J Pediatr. 2018. PMID: 29637375
The objective was to describe the pain and quality of life among children and adolescents with any osteogenesis imperfecta (OI) type over one intravenous bisphosphonate treatment cycle from a child and parental perspective. ...They selected evaluative pain de …
The objective was to describe the pain and quality of life among children and adolescents with any osteogenesis imperfecta (OI …
36 results